Purdue Pharma L.P.

Track this case

Case Number:

7:19-bk-23649

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

March 03, 2022
Purdue Reaches Final Terms On New $5.5B Ch. 11 Settlement

The mediator running negotiations between bankrupt drugmaker Purdue Pharma LP and the nine states that opposed its vacated Chapter 11 plan said Thursday the sides have reached a new deal that will see contributions from the Sackler family members who own the debtor increase to at least $5.5 billion.
March 02, 2022
Purdue Mediator Extends Talks To Work On Deal Terms

The mediator overseeing negotiations for a new Purdue Pharma restructuring plan Wednesday told a New York bankruptcy judge she is extending the talks, citing her authority to take more time if she's involved in drafting terms for a deal.
February 18, 2022
Sacklers Offer Another $1.6B For Purdue Ch. 11 Settlement

The mediator overseeing negotiations for a new Chapter 11 plan for Purdue Pharma reported Friday that the drugmaker's former owners in the Sackler family have agreed to add more than $1.6 billion to the $4.3 billion settlement they would have paid under the company's prior, scuttled bankruptcy plan.
February 17, 2022
Purdue Gets OK For 2-Week Opioid Suit Freeze Extension

A New York bankruptcy judge Thursday gave Purdue Pharma a two-week extension on an injunction pausing litigation against the company after being told the drugmaker is closing in on an agreement for a new Chapter 11 plan.
February 09, 2022
NY Judge OKs Canadian Entities' Late Purdue Ch. 11 Appeal

A New York federal judge on Wednesday approved a belated appeal filed by Canadian entities challenging Purdue Pharma's Chapter 11 plan, hours after Purdue said it had no problem with the appeal going forward before the Second Circuit.
February 08, 2022
Canadian Entities Seek Late Appeal In Purdue Ch. 11 Case

Canadian entities are seeking permission to file a late appeal to a New York federal court ruling that vacated Purdue Pharma's Chapter 11 plan, saying Tuesday there are unresolved issues related to their claims that won't be covered by the drugmaker's challenge in the Second Circuit.
February 04, 2022
Purdue Asks For New Extension On Opioid Suit Freeze

Purdue Pharma has asked a New York bankruptcy judge for another extension on the opioid litigation injunction that has been in place since it filed for bankruptcy, citing word that a settlement agreement is near on a modified reorganization plan and the considerable work that would follow.
February 01, 2022
Purdue Closing In On New Ch. 11 Deal With Sackler Family

A New York bankruptcy judge extended a mediation deadline Tuesday in the Chapter 11 case of Purdue Pharma after the mediator reported the parties were close to a deal that would see members of the Sackler family significantly increase their more than $4.3 billion in payments under the debtor's scuttled plan.
January 03, 2022
A Blockbuster Year Ahead For Health, Life Sciences Litigation

Health care and life sciences litigation is already red hot as 2022 begins and appears all but certain to intensify throughout the year as the clock ticks on time-sensitive lawsuits, the U.S. Supreme Court nears the end of its current term and opioid cases generate more trials and fresh drama. Here, Law360 explores five key litigation areas to watch.
December 06, 2021
Sackler Family Denies Pre-Ch. 11 Looting Of Purdue Pharma

Members of the Sackler family who own drugmaker Purdue Pharma told a New York federal judge Monday that they did not increase transfers of cash out of the business in the run-up to its 2019 Chapter 11 filing, and instead left the company with more unrestricted cash than ever before at that time.

← Previous
…
3
4
5
6
7
8
9
10
11
…
Next →